Proactive Investors
20 Oct 2026, 23:44 UTC · 51m ago
Small Cap Watch: Actinogen locks XanaMIA database and Kingfisher advances Broken Hill portfolio
Impact · against what's priced in
Actinogen and Kingfisher have provided concrete catalysts via a narrowed clinical readout window and new funding, respectively. Provaris has successfully increased its cash position for prototype development, though the impact is muted by the small scale of the raise.
- KFM+0.60
No priced-in read yet





